PlateletsAlan D. Michelson Gulf Professional Publishing, 2002 - 956 Seiten 2002 Best New Book in Medical Science - Professional/Scholarly Publishing Division of the Association of American Publishers Platelets is a comprehensive new textbook of 61 chapters and 1,100 pages (approx.) written by over 100 world leaders in the field. Platelets is a single definitive source of state-of-the-art knowledge about platelets. There has been no textbook that specifically and fully covers the entire field of platelet biology and clinical medicine. Platelets now fills this need. Platelets encompasses: platelet biology; platelet function testing; the role of platelets in disease; inherited and acquired disorders of platelet number and function; pharmacology of antiplatelet agents; pharmacology of agents to increase platelet numbers and/or function; platelet transfusion medicine; and gene therapy. The intended audience for Platelets includes hematologists, cardiologists, stroke physicians, blood bankers, pathologists, and researchers in thrombosis and hemostasis as well as students and fellows in these fields. * A single comprehensive source of state-of-the-art knowledge about platelets * Over 100 contributing authors from 13 countries * The authors of each chapter are world leaders in their fields * The definitive resource with 61 chapters, 1,100 pages (approx.), 12,000 references (approx.), 70 full color figures, 140 black and white figures, and 95 tables |
Inhalt
The Evolution of Mammalian Platelets | 3 |
Megakaryocyte Development and Platelet Formation | 21 |
Platelet Structure | 37 |
Platelet Turnover and Aging | 53 |
Platelet Receptors Kenneth J Clemetson I Introduction | 65 |
LeucineRich Repeat Family | 68 |
Immunoglobulin Superfamily | 70 |
Selectins | 74 |
Conclusions | 507 |
Psychiatric Disorders George N M Gurguis and A John Rush I Introduction | 513 |
Anxiety Disorders | 514 |
Mood Disorders | 515 |
Alcoholism | 518 |
Eating Disorders | 519 |
Childhood Developmental and Psychiatric Disorders | 521 |
Conclusions | 522 |
Glycosyl PhosphatidylinositolAnchored Proteins | 75 |
Miscellaneous Platelet Receptors | 76 |
The GPIbIXV Complex José A López and Michael C Berndt I Introduction | 85 |
Structure of the GPIbIXV Complex | 86 |
Gene Regulation and Expression of the GPIbIXV Complex | 87 |
BernardSoulier Syndrome | 89 |
Signaling Through the GPIbIXV Complex | 94 |
Conclusions | 97 |
Integrin απẞ3 Takaaki Hato Mark H Ginsberg and Sanford J Shattil I Introduction | 105 |
Ligand Binding Sites within abẞ3 | 106 |
OutsideIn Signaling | 109 |
Roles of InsideOut and OutsideIn Signaling in Platelet Aggregation | 110 |
Thrombin Receptors Addison R Tolentino and Wadie F Bahou I Thrombin | 117 |
Role of PARS in Disease | 122 |
Molecular and Developmental Genetics of PARS | 123 |
Thrombin Signaling in Platelets | 126 |
Development of PAR Inhibitors | 129 |
228 | 131 |
PSelectinPSGL1 and Other Interactions Between Platelets Leukocytes and Endothelium Rodger P McEver I Introduction | 139 |
Leukocyte Adhesion to Endothelial Cells Under Flow | 140 |
54 | 142 |
Leukocyte Adhesion to Platelets Under Flow | 143 |
Platelet Adhesion to Endothelial Cells Under Flow | 144 |
Multicellular Interactions of Platelets Leukocytes and Endothelial Cells Under Flow | 145 |
Conclusions | 148 |
Platelet Polymorphisms Vahid AfsharKharghan and Paul F Bray I Introduction | 157 |
Clinical Consequences of Platelet Polymorphisms | 164 |
Conclusions | 169 |
Platelet Secretion Guy L Reed I Introduction | 181 |
Platelet Granule Development | 183 |
Cell Signaling in Platelet Secretion | 184 |
Energy Requirements and the Kinetics of Cell Secretion | 186 |
Cellular Events in Exocytosis | 187 |
Signal Transduction During the Initiation Extension and Perpetuation of Platelet Plug Formation Donna Woulfe Jing Yang Nicolas Prevost Peter J O... | 197 |
Initiation | 198 |
Extension | 200 |
Perpetuation | 206 |
Conclusions | 207 |
Platelet Thrombus Formation in Flowing Blood Brian Savage and Zaverio M Ruggeri I Introduction | 215 |
Secondary Events Leading to Thrombus Propagation under Flow | 223 |
Conclusions | 225 |
Interactions Between Platelets and the Coagulation System Beth A Bouchard Saulius Butenas Kenneth G Mann and Paula B Tracy I Overview of the ... | 229 |
Model Systems Defining the Role of Platelets in Tissue FactorInitiated Thrombin Generation | 232 |
Intrinsic Platelet Proteins Involved in the Coagulant Response | 233 |
Factor XIaCatalyzed Factor IXaẞ Formation | 235 |
Intrinsic Xase Assembly and Function on the Activated Platelet Surface | 236 |
Prothrombinase Assembly and Function on the Activated Platelet Surface | 238 |
Positive and Negative Effectors of Platelet Coagulant Activity | 241 |
Summary | 244 |
PlateletDerived Microparticles Rienk Nieuwland and Augueste Sturk I Introduction | 255 |
Detection of Microparticles | 256 |
Microparticle Function | 260 |
Clinical Disorders Associated with Microparticles | 262 |
Platelet Function in the Newborn Sara J Israels I Introduction | 267 |
Platelet Count | 279 |
Platelet Aggregation | 291 |
Flow Cytometry | 297 |
Ultegra Rapid Platelet Function Analyzer | 317 |
Platelet Function Analyzer PFA100 | 325 |
PFA100 | 326 |
Conclusions | 332 |
Cone and Platelet Analyzer David Varon and Naphtali Savion I Introduction | 337 |
Applications of the CPA Method to Basic Research Studies | 340 |
Conclusions | 343 |
Perfusion Chambers Philip G de Groot and Jan J Sixma I Introduction | 347 |
Perfusion Devices | 348 |
Flow Devices | 350 |
Perfusate | 351 |
Influence of Shear on Platelet Reactivity | 352 |
Animal Models David H Lee and Morris A Blajchman I Introduction | 357 |
Platelet Survival and Tracking | 363 |
Interventions that Decrease Platelet Activity and Function | 364 |
Conclusions | 366 |
Part Three The Role of Platelets in Disease | 373 |
Atherosclerosis and Coronary Artery Disease Pascal J Goldschmidt Neuza Lopes and Lawrence E Crawford I Introduction | 375 |
Inflammation in Atherosclerosis | 376 |
A Necessary Mediator in Atherosclerosis | 376 |
The Atheromatous Plaque and Plaque Rupture | 376 |
Progress and Limitations | 381 |
Clinical Aspects and Treatment of Coronary Artery Disease | 383 |
Ischemic Cerebrovascular Disease Gregory J del Zoppo I Introduction | 399 |
Platelet Activation in the Development of Focal Cerebral Ischemia | 402 |
Hemorrhagic Transformation | 407 |
Antiplatelet Interventions in Cerebral Ischemia | 408 |
Carotid Artery Atherothrombotic Disease | 414 |
Conclusions | 416 |
Peripheral Vascular Disease Michael J Rohrer I Peripheral Arterial Occlusive Disease | 427 |
Peripheral Venous Disease | 430 |
Diabetes Mellitus Diethelm Tschoepe and Barbara MenartHoutermans I Introduction | 435 |
The Diabetic Thrombocytopathy and the Stem Cell Hypothesis | 437 |
Platelet Activation | 438 |
Therapeutic Consequences | 439 |
Renal Disease Jeffrey L Barnes I Introduction | 447 |
Mechanisms of PlateletMediated Glomerular Injury | 448 |
Therapeutic Approaches in Glomerular Disease | 450 |
Inflammation Matthias H F Klinger I The Cellular and Molecular Role of Platelets in Inflammation | 459 |
Platelets in Inflammatory Diseases | 461 |
Conclusion | 464 |
Antimicrobial Host Defense Michael R Yeaman and Arnold S Bayer I Mammalian Platelets are Multipurpose Inflammatory Cells | 469 |
Early Studies Were Interpreted to Suggest Platelets Promote Infection | 470 |
Platelets Contain Antimicrobial Polypeptides that Contribute to Host Defense | 474 |
Platelet Antimicrobial Peptides Likely Function Via Multiple Mechanisms of Action | 476 |
Platelet Antimicrobial Peptides Potentiate the Actions of Conventional Antibiotics | 477 |
Platelets Modulate Complement Activation | 478 |
Platelets are Integral to Antimicrobial Host Defense In Vivo | 479 |
Future Studies Will Address the Multiple Roles of Platelets in Antimicrobial Host Defense | 481 |
Summary | 482 |
Tumor Growth and Metastasis Simon Karpatkin I Introduction | 491 |
Platelet Tumor Adhesion | 492 |
Effect of Thrombin on PlateletTumor Adhesion and Pulmonary Metastasis | 493 |
Discussion | 496 |
Summary | 498 |
Alzheimers Disease QiaoXin Li Konrad Beyreuther and Colin L Masters I Introduction | 503 |
Platelet APP and Aẞ and Their Possible Functions | 505 |
Platelets and Alzheimers Disease | 506 |
Part Four Disorders of Platelet Number and Function | 539 |
The Clinical Approach to Disorders of Platelet Number and Function Alan D Michelson I Introduction | 541 |
Physical Examination | 543 |
Differential Diagnosis | 544 |
Specific Disorders | 545 |
Immune Thrombocytopenic Purpura James B Bussel I Introduction | 547 |
Etiology | 548 |
Diagnosis | 549 |
Treatment | 551 |
Summary | 555 |
HIV1Related Thrombocytopenia Simon Karpatkin I Introduction | 559 |
Incidence and Prognosis | 560 |
Mechanisms of Thrombocytopenia | 561 |
Composition of Immune Complexes | 563 |
HeparinInduced Thrombocytopenia Beng H Chong I Introduction | 571 |
Nomenclature | 572 |
Frequency of HIT | 574 |
Clinical Features of HIT | 576 |
Diagnosis | 577 |
Management | 581 |
DrugInduced Thrombocytopenia Richard H Aster I Introduction | 593 |
DrugInduced Platelet Destruction by Nonimmune Mechanisms | 594 |
DrugInduced Platelet Destruction by Immune Mechanisms | 595 |
Thrombotic Thrombocytopenic Purpura and HemolyticUremic Syndrome Joel L Moake I Introduction | 607 |
HemolyticUremic Syndrome | 611 |
Thrombocytopenia in Pregnancy Howard H W Chan Karamjit K Gill and John G Kelton I Introduction | 621 |
Differential Diagnosis | 622 |
Thrombocytopenia in the Newborn Irene A G Roberts and Neil A Murray I Introduction | 635 |
Incidence of Neonatal Thrombocytopenia | 636 |
Conditions Leading to Clinically Significant Neonatal Thrombocytopenia | 638 |
Clinical Impact of Neonatal Thrombocytopenia | 644 |
Principles of Management of Neonatal Thrombocytopenia | 645 |
Specific Approach to the Neonate with Significant Thrombocytopenia | 647 |
Thrombopoietin in the Fetus and Neonate | 649 |
Future Therapeutic Options for Neonatal Thrombocytopenia | 650 |
Summary | 651 |
Pseudothrombocytopenia Nicola Bizzaro I Introduction | 659 |
Other Anticoagulants | 660 |
Clinical Laboratory Procedures | 661 |
Pseudothrombocytopenia due to Platelet Satellitism | 662 |
Conclusions | 663 |
Thrombocytosis and Essential Thrombocythemia Ayalew Tefferi I Introduction | 667 |
Classification of Leading Causes | 668 |
Differentiating Reactive from Primary Thrombocytosis | 668 |
Pathogenesis and Biology | 668 |
Prognosis and Treatment | 671 |
Conclusion | 673 |
Inherited Disorders of Platelet Function Alan T Nurden and Paquita Nurden | 679 |
Introduction | 681 |
Other Giant Platelet Syndromes | 686 |
Familial Thrombocytopenias | 687 |
Defects of Secretion Storage Pool Disease | 689 |
Glanzmann Thrombasthenia | 690 |
Scott Syndrome | 694 |
Acquired Disorders of Platelet Function A Koneti Rao I Introduction | 701 |
Uremia | 702 |
Myeloproliferative Diseases | 704 |
Acute Leukemias and Myelodysplastic Syndromes | 706 |
Acquired Storage Pool Disease | 707 |
Liver Disease | 708 |
Cardiopulmonary Bypass Brian Richard Smith Henry M Rinder and Christine S Rinder I Introduction | 727 |
Inflammation and CPB | 728 |
Clinical Hemostatic Alterations during and after CPB | 729 |
Quantitative Platelet Abnormalities during CPB | 730 |
Qualitative Platelet Abnormalities during CPB | 731 |
Diagnostic and Therapeutic Issues in CPB Hemostasis | 733 |
Antiplatelet Therapy | 743 |
Aspirin Eric H Awtry and Joseph Loscalzo I Introduction | 745 |
Mechanisms of Benefit in Cardiovascular Disease | 747 |
Aspirin in the Treatment of Acute Cardiovascular Disease | 748 |
Aspirin for Secondary Prevention of Cardiovascular Events | 751 |
Aspirin for Primary Prevention of Cardiovascular Disease | 753 |
Aspirin Therapy after Revascularization | 755 |
Aspirin in Other Clinical Settings | 756 |
Adverse Effects | 757 |
Epidemiology of Aspirin Use | 758 |
ConclusionsRecommendations | 759 |
GPIIbIIIa Antagonists Ramtin Agah Edward F Plow and Eric J Topol I Introduction | 769 |
GPIIbIIIa Signaling Mechanisms | 770 |
The GPIIbIIIa Antagonists | 771 |
GPIIbIIIa Blockade during Coronary Interventions | 772 |
GPIIbIIIa Blockade in the Medical Management of Acute Coronary Syndromes | 777 |
Side Effects | 779 |
Emerging Indications | 780 |
Conclusions | 781 |
Clopidogrel and Ticlopidine Ronan Curtin Dermot Cox and Desmond Fitzgerald I Introduction | 787 |
Pharmacokinetics | 789 |
Side Effects | 795 |
Drug Interactions | 796 |
Conclusions | 797 |
Dipyridamole Wolfgang G Eisert I Introduction | 803 |
Mechanisms of Action | 804 |
Side Effects | 810 |
Cilostazol Yasuo Ikeda Toshiki Sudo and Yukio Kimura I Introduction | 817 |
Antithrombotic Effects | 819 |
Other Effects | 820 |
Therapy to Increase Platelet Numbers andor Function | 825 |
Thrombopoietin David J Kuter I Introduction | 827 |
The Thrombopoietin Gene and its Regulation | 828 |
Functions of Thrombopoietin | 829 |
Physiology of Thrombopoietin | 830 |
Pathophysiology of Thrombopoietin | 832 |
Recombinant Thrombopoietins | 833 |
Clinical Uses of Recombinant ThrombopoietinAnimal Studies | 834 |
Clinical Uses of Recombinant ThrombopoietinHuman Studies | 835 |
Adverse Effects of Thrombopoietin | 837 |
Interleukin 11 | 845 |
Desmopressin | 855 |
Factor VIIa | 867 |
Platelet Storage and Transfusion | 877 |
Platelet Transfusion in Infants and Children | 907 |
Platelet Substitutes and Novel Methods of Platelet Preservation | 915 |
Gene Therapy for Platelet Disorders | 927 |
Andere Ausgaben - Alle anzeigen
Häufige Begriffe und Wortgruppen
Acad actin activated platelets agonists antigen arterial aspirin aẞ associated atherosclerosis Biochem bleeding Cell Biol Chapter Chem Circulation Clin clinical coagulation collagen coronary cytoplasmic cytoskeleton defect disease domain effect endothelial cells expression factor VIIIa factor Xa fibrinogen flow cytometry formation gene genetic GPIb GPIb-IX-V complex GPIba GPIIb-IIIa GPVI granules Haematol Haemost hemostasis hemostatic human platelets increased induced infarction inhibition inhibitors integrin interaction intracellular ischemic kinase leukocyte ligand mechanism mediated megakaryocytes mice microparticles molecular molecules monoclonal antibody mutation myocardial neonatal normal P-selectin PAR1 PAR4 patients peptide phosphorylation plasma plate platelet activation platelet adhesion platelet aggregation platelet count platelet function platelet glycoprotein platelet membrane platelet surface polymorphism Proc proplatelet protein prothrombin release response role sequence shear signaling stroke structure studies subunit syndrome Thromb thrombin receptor thrombocytopenia thrombosis tion tissue tyrosine vascular vitro vivo von Willebrand disease von Willebrand factor whole blood Willebrand factor
Verweise auf dieses Buch
Thrombus and Stroke Ajay K. Wakhloo,Matthew J. Gounis,Baruch B. Lieber,Robert A. Mericle,Italo Linfante Keine Leseprobe verfügbar - 2008 |
Thrombus and Stroke Ajay K. Wakhloo,Matthew J. Gounis,Baruch B. Lieber,Robert A. Mericle,Italo Linfante Keine Leseprobe verfügbar - 2008 |